Medical Devices

RS3Dprints

Brief Description

3D printing for medical and food applications. Mass producing alternative steaks from alternative ground beef. Scalable solution for 3D printed alternative meat.

The Cryolithographic Technology was initially developed to produce biological organs for organ transplant. Realizing that there was an immediate commercial opportunity in food production, RS3Dprints was spun out of the lab.

Inventors

Boris Rubinsky, Ze'ev Shaked, Michal Adamkievicz

Company Founders

Dan Rubinsky

Timeline 2016. Company founded

Organos, Inc.

Brief Description Developer of cardiac micro physiological systems designed to offer three-dimensional (3D) human cardiac tissue models for advanced analysis. The company's data science ecosystem is used to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, thereby enabling the health industry to perform safer and cheaper drug development activities. Inventors

Kevin Healy, SoonGweon Hong, Luke Lee, Peter Loskill, Anurag Mathur Pia, Rodriguez Nunez...

OncoRx Pharmaceuticals, Inc.

Brief Description

OncoRx Pharmaceuticals is an early-stage pharmaceutical company discovering and developing targeted therapies that control the progression of invasive malignant cancer. OncoRx has identified and tested drugs that markedly alter the sustained directional mobility, the uncontrolled cell cycle, and t​​he unrestrained growth and proliferation of intrinsically and acquired therapy-resistant tumors. Unlike non-aggressive primary tumors, the growth, progression and invasiveness of therapy-resistant tumors are not effectively controlled with currently available cancer therapies...

Oncobionic

Brief Description

Oncobionic commercialized irreversible electroporation (IRE) technology, a minimally invasive treatment for tumors that revolutionized cancer therapy. The minimally invasive surgical system delivers 1,500 volts of electric current through needle-like probes, ablating the targeted area, making it possible to remove unresectable tumors near critical structures and major blood vessels without cuts or incisions. IRE exclusively targets the tumor’s cell membranes, leaving critical organs, vasculature, ducts and nerves completely unharmed.

The IRE...

NanoVasc

Brief Description

NanoVasc, Inc. is a medical device company that designs and manufactures biomimetic materials that are non-thrombogenic, durable and demonstrate long-term patency. The Company uses an electrospinning process to manufacture scaffolds in a multitude of shapes and sizes, and then application-specific modifications are applied to the scaffolds surface in order to achieve desired results. These specific modifications are designed to optimize the devices outcome based on its delivery location. The Company's first product is a synthetic vascular graft for hemodialysis access....

Microreactor Technologies

Brief Description

Developer of miniature bioreactor technology platforms. The company offers improved cell fermentation and cultivation productivity services. It develops and operates Micro-24, fermentation and cell culture system which runs up to 24 simultaneous experiments with independent control of each reactor's gas supply, temperature, and pH.

Microreactor Technologies, Inc. was acquired by Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, in 2010.

Inventors

Michel Maharbiz, Jay Keasling, Roger Howe, William Holtz

Timeline...

MediFuel Inc.

Brief Description

MediFuel is the first tiny, Biological Fuel Cell (BFC) Company solving the power problem of the next generation of implantable medical devices – a market which is projected to reach over a billion dollars. The company's technology is a GlucoCell ™ , a MEMS based power chip that harnesses your own body’s natural energy resource – glucose and converts it into usable electrical energy. The GlucoCell ™ has the potential to provide self-sustaining device operation at a fraction of the cost and at 1/100th the size of competing battery technologies. The company’s mission is to...

Mammoth Biosciences

Brief Description

Mammoth’s vision is to provide a CRISPR-based platform on which an infinite number of tests can be built by both ourselves and our partners - democratizing access to an endless variety of tests for bio sensing in healthcare, as well as across industries such as agriculture, manufacturing, forensics, and more.

Inventors

Jennifer Doudna, Alexandra Seletsky, Amanda Mok, Brittney Wai-Li Thornton, David Frank Savage, Dylan Smock, Eli Dugan, Emeric Jean Charles, Gavin Knott, James Doudna Cate, John Desmarais, Liana Lareau, Mariya Lukarska, Mitchell O'Connell, Nicholas...

Magnetic Insight

Brief Description

Magnetic Insight is developing solutions in Magnetic Particle Imaging (MPI), a ground-breaking technology that will overcome major deficiencies with current clinical and translational research imaging techniques.

Magnetic Insight Inc. was founded by one of the leading research groups in the global field of Magnetic Particle Imaging from UC Berkeley. Developed over the past decade in the research lab of UC Berkeley Bioengineering and Electrical Engineering and Computer Science Professor Steven Conolly, MPI has proven in animal studies to generate high-contrast...

Iota Biosciences

Brief Description

Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning 'neural dust' technology invented at the University of California, Berkeley, Iota Biosciences is building a platform for the future of bioelectronic medicine.

Inventors

Michel Maharbiz, Jose Carmena

Company Founders

Aaron Hall (UC Berkeley, Ph.D., Doctor of Philosophy, Materials Science & Engineering), Ilan Gur (UC Berkeley, B.A., M.S., Ph.D., Doctor of Philosophy, Materials Science & Engineering...